News
BD and Penn Institute Ink Collaboration to Advance Immunotherapy
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to develop a
Target's Shrink Normalization Emerges as Key Margin Stabilizer
Target Corporation’s TGT ongoing shrink normalization is shaping up as one of the most visible contributors to near-term margin stabilization, even as top-line trends remain pressured. After
How Goldman Is Scaling AI to Transform Its Business Operations
The Goldman Sachs Group (GS) is executing a firmwide artificial intelligence (AI) transformation that spans trading, investment banking, asset management, and internal productivity, with a clear
What Makes Unitil (UTL) a New Buy Stock
Unitil (UTL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the
All You Need to Know About Banzai International, Inc. (BNZI) Rating Upgrade to Buy
Banzai International, Inc. (BNZI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates
Kinross Gold (KGC) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Micron (MU) Is Up 10.28% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Heico (HEI) Upgraded to Buy: Here's Why
Heico Corporation (HEI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
EyePoint (EYPT) Is Up 9.01% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why
Keros Therapeutics, Inc. (KROS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful
All You Need to Know About GE (GE) Rating Upgrade to Buy
Investors might want to bet on GE Aerospace (GE), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock
Rio Tinto (RIO) Is Up 3.52% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Agnico Eagle Mines (AEM) Is Up 3.53% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Jabil (JBL) Is Up 1.91% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Genpact (G) Upgraded to Buy: Here's Why
Genpact (G) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most
Fox (FOXA) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Gain Therapeutics (GANX) Upgraded to Buy: Here's Why
Gain Therapeutics, Inc. (GANX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces
What Makes Southern Copper (SCCO) a Strong Momentum Stock: Buy Now?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
What Makes Huron Consulting (HURN) a New Buy Stock
Investors might want to bet on Huron Consulting (HURN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one
Ensign Group (ENSG) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on Ensign Group (ENSG), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
Are You Looking for a Top Momentum Pick? Why Fox Corporation (FOX) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
What Makes Aveanna Healthcare (AVAH) a Strong Momentum Stock: Buy Now?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Surf Air Mobility Inc. (SRFM) Upgraded to Buy: Here's Why
Surf Air Mobility Inc. (SRFM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings
FEIM Downgraded to Neutral Amid Margin and Cash Headwinds
Frequency Electronics, Inc. FEIM, a niche leader in precision time and frequency control systems, has been downgraded from “Outperform” to “Neutral,” citing a mix of strategic achievements and